Aaron Falcione - Mar 29, 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Human Resources Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Aaron Falcione
Stock symbol
OGN
Transactions as of
Mar 29, 2025
Transactions value $
-$105,038
Form type
4
Date filed
4/2/2025, 05:45 PM
Previous filing
Feb 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +8.42K +18.31% $0.00 54.4K Mar 31, 2025 Direct
transaction OGN Common Stock Tax liability -$41.9K -2.89K -5.3% $14.51 51.5K Mar 29, 2025 Direct F1
transaction OGN Common Stock Options Exercise $0 +6.73K +13.07% $0.00 58.2K Mar 31, 2025 Direct
transaction OGN Common Stock Tax liability -$37.6K -2.59K -4.45% $14.51 55.7K Mar 31, 2025 Direct F1
transaction OGN Common Stock Options Exercise $0 +3.58K +6.43% $0.00 59.2K Mar 31, 2025 Direct
transaction OGN Common Stock Tax liability -$25.6K -1.76K -2.98% $14.51 57.5K Mar 31, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Stock Option (right to buy) Award $0 +165K $0.00 165K Mar 31, 2025 Common Stock 165K $14.89 Direct F2
transaction OGN Restricted Stock Units Award $0 +33.6K $0.00 33.6K Mar 31, 2025 Common Stock 33.6K Direct F3, F4
transaction OGN Restricted Stock Units Options Exercise $0 -8.42K -33.33% $0.00 16.8K Mar 31, 2025 Common Stock 8.42K Direct F3, F5
transaction OGN Restricted Stock Units Options Exercise $0 -6.73K -50% $0.00 6.73K Mar 31, 2025 Common Stock 6.73K Direct F3, F6
transaction OGN Restricted Stock Units Options Exercise $0 -3.58K -100% $0.00 0 Mar 31, 2025 Common Stock 3.58K Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
F2 The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.
F3 Each RSU converts into one share of Organon common stock.
F4 The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.
F5 On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.
F6 On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026.
F7 On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.